|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/22 | |||
| G01N 33/53 | |||
| C12N 15/68 | |||
| C12N 5/10 | |||
| A61P 25/00 | |||
| A61P 35/00 | |||
| A61P 19/02 | |||
| A61P 29/02 |
| (11) | Patento numeris | 2485760 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10766193.6 |
| Europos patento paraiškos padavimo data | 2010-10-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-08-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-07-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/051960 |
| Data | 2010-10-08 |
| (87) | Numeris | WO 2011/049758 |
| Data | 2011-04-28 |
| (30) | Numeris | Data | Šalis |
| 576522 | 2009-10-09 | US |
| (72) |
WILD, Kenneth, D., US
TREANOR, James, J.s., US
HUANG, Haichun, US
INOUE, Heather, US
ZHANG, Tie, J., US
MARTIN, Frank, US
|
| (73) |
Amgen, Inc,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
E. R. Squibb & Sons, L.L.C., Route 206 & Province Line Road, Princeton, NJ 08540, US |
| (54) | HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORS |
| HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORS |